Clinical Trial Update: Relative Bioavailability Study of Nadolol (1 x 80 mg) Tablets Under Fasting Conditions [Phase 1]

View source ↗

Summary

Phase 1 relative bioavailability study of Nadolol 80 mg tablets under fasting conditions has completed. The study investigates the pharmacokinetics of nadolol i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angina Pectoris
• Hypertension
• Migraine

Drugs mentioned

• Nadolol (Nadolol)

Snippet

Sponsor: Sandoz | Conditions: High Blood Pressure, Migraine Headaches | Phase 1 | Status: COMPLETED